Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.
BACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2865539?pdf=render |
id |
doaj-50dd6d3b7bab467798b5c8f5f05eb756 |
---|---|
record_format |
Article |
spelling |
doaj-50dd6d3b7bab467798b5c8f5f05eb7562020-11-25T01:35:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-0155e1050710.1371/journal.pone.0010507Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.Ricardo ValladaresDhyana SankarNan LiEmily WilliamsKin-Kwan LaiAsmaa Sayed AbdelgelielClaudio F GonzalezClive H WasserfallJoseph LarkinDesmond SchatzMark A AtkinsonEric W TriplettJosef NeuGraciela L LorcaBACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri isolated from diabetes resistant rats to determine the effect on type 1 diabetes development. METHODOLOGY/PRINCIPAL: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1 diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L. johnsonii fed animals low levels of the pro-inflammatory cytokine IFNgamma were correlated with low levels of iNOS and high levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin. CONCLUSIONS: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder.http://europepmc.org/articles/PMC2865539?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ricardo Valladares Dhyana Sankar Nan Li Emily Williams Kin-Kwan Lai Asmaa Sayed Abdelgeliel Claudio F Gonzalez Clive H Wasserfall Joseph Larkin Desmond Schatz Mark A Atkinson Eric W Triplett Josef Neu Graciela L Lorca |
spellingShingle |
Ricardo Valladares Dhyana Sankar Nan Li Emily Williams Kin-Kwan Lai Asmaa Sayed Abdelgeliel Claudio F Gonzalez Clive H Wasserfall Joseph Larkin Desmond Schatz Mark A Atkinson Eric W Triplett Josef Neu Graciela L Lorca Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE |
author_facet |
Ricardo Valladares Dhyana Sankar Nan Li Emily Williams Kin-Kwan Lai Asmaa Sayed Abdelgeliel Claudio F Gonzalez Clive H Wasserfall Joseph Larkin Desmond Schatz Mark A Atkinson Eric W Triplett Josef Neu Graciela L Lorca |
author_sort |
Ricardo Valladares |
title |
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. |
title_short |
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. |
title_full |
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. |
title_fullStr |
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. |
title_full_unstemmed |
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. |
title_sort |
lactobacillus johnsonii n6.2 mitigates the development of type 1 diabetes in bb-dp rats. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-01-01 |
description |
BACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation have been implicated in a variety of diseases within and outside of the gastrointestinal tract. With this model in mind, recent studies have shown a link between diet, composition of intestinal microbiota, and type 1 diabetes pathogenesis. In the BioBreeding rat model of type 1 diabetes, comparison of the intestinal microbial composition of diabetes prone and diabetes resistant animals found Lactobacillus species were negatively correlated with type 1 diabetes development. Two species, Lactobacillus johnsonii and L. reuteri, were isolated from diabetes resistant rats. In this study diabetes prone rats were administered pure cultures of L. johnsonii or L. reuteri isolated from diabetes resistant rats to determine the effect on type 1 diabetes development. METHODOLOGY/PRINCIPAL: Findings Results Rats administered L. johnsonii, but not L. reuteri, post-weaning developed type 1 diabetes at a protracted rate. Analysis of the intestinal ileum showed administration of L. johnsonii induced changes in the native microbiota, host mucosal proteins, and host oxidative stress response. A decreased oxidative intestinal environment was evidenced by decreased expression of several oxidative response proteins in the intestinal mucosa (Gpx1, GR, Cat). In L. johnsonii fed animals low levels of the pro-inflammatory cytokine IFNgamma were correlated with low levels of iNOS and high levels of Cox2. The administration of L. johnsonii also resulted in higher levels of the tight junction protein claudin. CONCLUSIONS: It was determined that the administration of L. johnsonii isolated from BioBreeding diabetes resistant rats delays or inhibits the onset of type 1 diabetes in BioBreeding diabetes prone rats. Taken collectively, these data suggest that the gut and the gut microbiota are potential agents of influence in type 1 diabetes development. These data also support therapeutic efforts that seek to modify gut microbiota as a means to modulate development of this disorder. |
url |
http://europepmc.org/articles/PMC2865539?pdf=render |
work_keys_str_mv |
AT ricardovalladares lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT dhyanasankar lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT nanli lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT emilywilliams lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT kinkwanlai lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT asmaasayedabdelgeliel lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT claudiofgonzalez lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT clivehwasserfall lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT josephlarkin lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT desmondschatz lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT markaatkinson lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT ericwtriplett lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT josefneu lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats AT gracielallorca lactobacillusjohnsoniin62mitigatesthedevelopmentoftype1diabetesinbbdprats |
_version_ |
1725065797959680000 |